Case Based Roundtable Series

An expert discusses evolving best practices in the diagnosis and management of Demodex blepharitis, highlighting collarettes as pathognomonic and sufficient for diagnosis, the importance of targeting high-risk patient groups for treatment, and the promise of a new pharmacologic therapy that shifts care toward a more effective, flexible, and patient-centered approach.

Mark Lobanoff, MD​, discusses how the IC-8 Apthera small aperture intraocular lens functions as a pinhole-based optical system to create extended depth of focus, demonstrates successful salvage of a complicated light adjustable lens case through lens exchange after pinhole testing, and emphasizes the critical importance of controlling central 3-mm zone astigmatism and ensuring nighttime pupil size remains under 5 mm for optimal visual outcomes in keratoconus patients requiring adjunctive photorefractive keratectomy.

Michael W. Stewart, MD​, discusses how high-dose aflibercept (8 mg) can achieve better anatomical and visual outcomes compared with standard anti-VEGF therapies in patients with treatment-resistant diabetic macular edema and neovascular age-related macular degeneration, demonstrating improved retinal drying and extended treatment durability through 3 detailed clinical cases.

1 expert is featured in this series.

Christopher E. Starr, MD, discusses how to identify, diagnose, and effectively treat Demodex blepharitis in both preoperative cataract patients and contact lens wearers, highlighting the importance of eradicating these mites using FDA-approved lotilaner ophthalmic solution to improve visual outcomes and quality of life.

Steven J. Dell, MD discusses how managing cataract surgery in post-refractive surgery patients presents unique challenges including accurate IOL power calculation, epithelial healing variability, and the need for specialized approaches such as piggyback IOLs and careful lens selection to meet high patient expectations for spectacle independence.

In this program, Dr. Daniel Kiernan shares insights from a recent Ophthalmology Times case-based roundtable meeting where he discussed two cases of DME, assessed the clinical presentations and treatment choices, and evaluated patient outcomes.

Dr. Daniel Kiernan shares insights from a recent Ophthalmology Times case-based roundtable meeting where he discusses two cases of neovascular age-related macular degeneration, reviews the clinical presentations, and assesses patient-specific factors in determining treatment choices.